Clinical Guest Contributors

  1. Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease Patients 5/27/2025

    Ocugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.

  2. Don't Miss These 2025–2026 EMA IDMP Compliance Deadlines For Product Management Services 5/22/2025

    The EMA's Product Management Services will serve as a comprehensive database for consistent identification of medicines internationally. One deadline is quickly approaching on May 31. Are you ready?

  3. Why Sponsors Must Build Trials That Acknowledge All Patients' Needs 5/22/2025

    Servier Pharmaceuticals' Susan Pandya discusses how sponsors can translate a belief in patient centricity into action by creating more accessible, inclusive, and patient-friendly pathways to participation.

  4. What's The Risk Of Letting Researchers Use LLMs? 5/21/2025

    Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.

  5. Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action 5/20/2025

    Celebrate Clinical Trials Day 2025 with these industry experts as they share experiences and advice related to trial design, regulatory and compliance, and outsourcing challenges.

  6. Celebrating Clinical Trials Day, Part 1: Putting The Patient First 5/20/2025

    Celebrate Clinical Trials Day 2025 with these industry experts sharing their experiences and advice for putting the patient first.

  7. Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources 5/20/2025

    Celebrate Clinical Trials Day 2025 with these industry experts, who share their experiences in and advice for establishing partnerships and finding the best talent.

  8. Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One 5/19/2025

    Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards. 

  9. How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two 5/19/2025

    Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.

  10. Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake 5/16/2025

    How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.